NET Remedies #2 Metal Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4202-2
FDA Drug Recall #D-0948-2019 — Class I — July 20, 2018
Recall Summary
| Recall Number | D-0948-2019 |
| Classification | Class I — Serious risk |
| Date Initiated | July 20, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | King Bio Inc. |
| Location | Asheville, NC |
| Product Type | Drugs |
| Quantity | 16495 bottles |
Product Description
NET Remedies #2 Metal Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4202-2
Reason for Recall
Microbial contamination
Distribution Pattern
U.S.A. Nationwide, Canada, and Australia.
Lot / Code Information
Lots: NR-031516M Exp. 03/19; NR-073015D Exp. 09/19; NR-010617B Exp. 01/20; NR-011216M Exp. 01/19; NR-042717D Exp. 09/19; NR-051116B Exp. 05/19; NR-061616N Exp. 06/19; NR-080116E Exp. 08/19; NR-090115B Exp. 09/18; NR-090616B Exp. 09/19; NR-101416B Exp. 10/19; NR-120815R Exp. 12/18; NR-081017B Exp. 08/19; NR-020118B Exp. 02/20; NR-022318B Exp. 02/20; NR-101017B Exp. 10/19; NR-120317B Exp. 12/19
Other Recalls from King Bio Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0739-2019 | Class I | Dr. King's SafeCare Rx LymePlex, 2 fl. oz. (59 ... | Jul 20, 2018 |
| D-0863-2019 | Class I | Dr. King's SafeCare Rx CS-Lymph Hodgkins, 2 fl.... | Jul 20, 2018 |
| D-0885-2019 | Class I | Dr. King's SafeCare Rx Smoke Control, 2 fl. oz.... | Jul 20, 2018 |
| D-0786-2019 | Class I | Dr. King's SafeCare Rx Gout Symptom Relief, 2 f... | Jul 20, 2018 |
| D-0651-2019 | Class I | Dr. King's Natural Medicine Homeopathic Climate... | Jul 20, 2018 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.